- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Gilead Sciences acquires Immunomedics in $21bn deal

Immunomedics will now be a wholly owned subsidiary of Gilead. Credit: Steve Buissinne deom Pixabay.